Home / Drug shortages / Lisdexamfetamine Dimesylate Capsule

Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Mylan Pharmaceuticals Inc., a Viatris Company

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Mylan Pharmaceuticals Inc., a Viatris Company with status Current. The shortage was first posted on 07/14/2023.

Shortage Details

Status
Current
Company
Mylan Pharmaceuticals Inc., a Viatris Company
Package NDC
0378-6858-77
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77)
Initial Posting
07/14/2023
Revised Date

FDA data resources